We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Idera Pharmaceuticals Announces Favorable Data from Phase 1b Study of IMO-2055

News   Jan 23, 2012

 
Idera Pharmaceuticals Announces Favorable Data from Phase 1b Study of IMO-2055
 
 
 

RELATED ARTICLES

A Change in Cell Logistics Helps Cancer Become Resistant

News

Researchers have discovered that breast cancers which had become resistant to hormone therapy have a molecular "advantage" that helps the cells successfully evade hormone therapies.

READ MORE

Could Mimicking How Astronauts Prep for Spaceflight Benefit Cancer Patients?

News

Researchers think that by mimicking an astronaut's schedule of exercising before, during, and after a mission, cancer patients could reduce the long-term impact their treatments can have on their bodies.

READ MORE

Spread of Breast Cancer Stopped by Blocking Enzyme

News

By blocking the activity of a single enzyme it is possible to prevent a common type of breast cancer from spreading to distant organs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE